Cisplatin-vindesine-mitomycin (MVP) vs cisplatin-ifosfamide-vinorelbine (PIN) vs carboplatin-vinorelbine (CaN) in patients with advanced non-small-cell lung cancer (NSCLC): a FONICAP randomized phase II study. Italian Lung Cancer Task Force (FONICAP (Q36293020)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Cisplatin-vindesine-mitomycin (MVP) vs cisplatin-ifosfamide-vinorelbine (PIN) vs carboplatin-vinorelbine (CaN) in patients with advanced non-small-cell lung cancer (NSCLC): a FONICAP randomized phase II study. Italian Lung Cancer Task Force (FONICAP |
scientific article |
Statements
1 reference
Cisplatin-vindesine-mitomycin (MVP) vs cisplatin-ifosfamide-vinorelbine (PIN) vs carboplatin-vinorelbine (CaN) in patients with advanced non-small-cell lung cancer (NSCLC): a FONICAP randomized phase II study. Italian Lung Cancer Task Force (FONICAP (English)
1 reference
Baldini E
1 reference
Tibaldi C
1 reference
Ardizzoni A
1 reference
Salvati F
1 reference
Antilli A
1 reference
Portalone L
1 reference
Barbera S
1 reference
Romano F
1 reference
De Marinis F
1 reference
Migliorino MR
1 reference
Noseda MA
1 reference
Borghini U
1 reference
Crippa M
1 reference
Ferrara G
1 reference
Raimondi M
1 reference
Fioretti M
1 reference
Bandera M
1 reference
Pennucci MC
1 reference
Galeasso G
1 reference
Cacciani GC
1 reference
Lepidini G
1 reference
Sunseri G
1 reference
Lanfranco C
1 reference
Rinaldi M
1 reference
Rosso R
1 reference
1 June 1998
1 reference
1 reference
2367-2370
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference